M Matsui Selected Research

M Matsui Research Topics

Disease

4	Schizophrenia (Dementia Praecox) 10/2001 - 06/2000
3	Neoplasms (Cancer) 03/2014 - 02/2000
2	Erythema 01/2022 - 03/2001
2	Leukemia 01/2017 - 01/2017
2	Carcinogenesis 01/2016 - 03/2014
2	Glioblastoma (Glioblastoma Multiforme) 04/2014 - 08/2013
2	Squamous Cell Carcinoma of Head and Neck 03/2014 - 02/2001
2	Sunburn 03/2013 - 03/2001
2	Necrosis 11/2003 - 01/2000
2	Infections 10/2002 - 12/2001
2	Carcinoma (Carcinomatosis) 07/2000 - 06/2000
1	Acne Vulgaris 01/2022
1	Gingival Recession 10/2017
1	Sialadenitis 02/2017
1	Inflammation (Inflammations) 01/2016
1	Septic Shock (Toxic Shock Syndrome) 04/2015
1	Prediabetic State (Prediabetes) 02/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014
1	Neoplasm Metastasis (Metastasis) 03/2014
1	Adenoviridae Infections (Adenovirus Infections) 03/2014
1	Pneumothorax 01/2012
1	Severe Acute Respiratory Syndrome 01/2010
1	CADASIL 07/2006
1	Varicose Veins (Varicose Vein) 07/2006
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 12/2005
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2005
1	Scleromyxedema (Lichen Myxedematosus) 01/2003
1	Multiple Sclerosis 10/2002
1	Pica (Geophagia) 04/2002
1	Vomiting 04/2002
1	Stroke (Strokes) 10/2001
1	Alzheimer Disease (Alzheimer's Disease) 10/2001
1	Atrophy 10/2001
1	Communication Disorders (Communication Disorder) 10/2001
1	Hepatocellular Carcinoma (Hepatoma) 07/2001
1	Body Weight (Weight, Body) 07/2001
1	Lung Injury 03/2001
1	Shock 03/2001

Drug/Important Bio-Agent (IBA)

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2003 - 12/2000
3	tandospironeIBA 10/2001 - 06/2000
2	CytokinesIBA 02/2017 - 04/2015
2	Peptides (Polypeptides)IBA 02/2017 - 07/2001
2	Dasatinib (BMS 354825)FDA Link 01/2017 - 01/2017
2	Biological ProductsIBA 03/2014 - 01/2001
2	VaccinesIBA 01/2010 - 12/2001
2	AntibodiesIBA 10/2002 - 05/2000
2	Proteins (Proteins, Gene)FDA Link 12/2001 - 01/2001
2	Antipsychotic Agents (Antipsychotics)IBA 10/2001 - 05/2001
2	tapasinIBA 07/2001 - 02/2001
2	TeaIBA 03/2001 - 06/2000
1	Trichloroacetic AcidIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017
1	Interleukin-17 (Interleukin 17)IBA 02/2017
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2017
1	Bone Morphogenetic Protein 2IBA 01/2016
1	Lipase (Acid Lipase)FDA Link 04/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2015
1	BilirubinIBA 04/2015
1	Thyroid HormonesIBA 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 02/2015
1	Anaplastic Lymphoma KinaseIBA 04/2014
1	LigandsIBA 04/2014
1	pleiotrophin (HARP)IBA 04/2014
1	adenovirus receptorIBA 03/2014
1	Protein Kinases (Protein Kinase)IBA 03/2014
1	Cyclin D2IBA 08/2013
1	Melanins (Melanin)IBA 03/2013
1	RNA Splice SitesIBA 07/2006
1	8-Hydroxy-2'-DeoxyguanosineIBA 12/2005
1	Pyrimidine DimersIBA 12/2005
1	Interleukin-2 (IL2)IBA 11/2003
1	Interferon-gamma (Interferon, gamma)IBA 11/2003
1	IonomycinIBA 11/2003
1	Tetradecanoylphorbol AcetateIBA 11/2003
1	Brefeldin AIBA 11/2003
1	Interleukin-4 (Interleukin 4)IBA 11/2003
1	Monensin (Coban)IBA 11/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2003
1	Carmine (Natural Red 4)IBA 04/2002
1	Apomorphine FDA Link 04/2002
1	Cisplatin (Platino)FDA LinkGeneric 04/2002
1	KaolinIBA 04/2002
1	Copper Sulfate (Sulfate, Copper)FDA Link 04/2002
1	Apolipoproteins E (ApoE)IBA 10/2001
1	ApolipoproteinsIBA 10/2001
1	MercuryIBA 07/2001
1	Serotonin (5 Hydroxytryptamine)IBA 05/2001
1	Haloperidol (Haldol)FDA LinkGeneric 05/2001
1	Biperiden (Akineton)FDA Link 05/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2001
1	Pharmaceutical PreparationsIBA 03/2001
1	Leucine (L-Leucine)FDA Link 03/2001
1	Messenger RNA (mRNA)IBA 03/2001
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2001
1	gallocatechol (epigallocatechin)IBA 03/2001
1	Immunoglobulin M (IgM)IBA 03/2001

Therapy/Procedure

2	Therapeutics 04/2014 - 01/2001
1	Conservative Treatment 01/2012
1	Punctures 10/2002